| Bioactivity | Rocepafant (BN 50730; LAU-8080) is a specific platelet activating factor (PAF) antagonist. Rocepafant can be used in rheumatoid arthritis and nervous system research[1]. |
| CAS | 132579-32-9 |
| Formula | C26H23ClN6OS2 |
| Molar Mass | 535.08 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Silva CL,et al. Formation of a highly stable complex between BN 50730 [tetrahydro-4,7,8,10 methyl-1(chloro-2 phenyl)-6 (methoxy-4 phenyl-carbamoyl)-9 pyrido [4',3'-4,5] thieno [3,2-f] triazolo-1,2,4 [4,3-a] diazepine-1,4] and the platelet-activating factor receptor in rabbit platelet membranes. Biochem Pharmacol. 1996 Jan 26;51(2):193-6. |
Rocepafant
CAS: 132579-32-9 F: C26H23ClN6OS2 W: 535.08
Rocepafant (BN 50730; LAU-8080) is a specific platelet activating factor (PAF) antagonist. Rocepafant can be used in rhe
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.